First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.

Key market opportunities in the IVD Raw Materials sector include the expanding demand for high-purity materials due to ...

Australian startup All G has secured A$10M ($6.6M) and signed a joint venture with Armor Protéines to expand production of ...

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

LUND, SE / ACCESS Newswire / December 9, 2025 / Alligator Bioscience (STO:ATORX) today comments on the announcement by Shanghai Henlius Biotech, Inc. that applications for Phase 2/3 clinical trials of ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

Lyon, France and Liège, Belgium – – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced the ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('Company' or 'Kraig Labs'), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...